Boston Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-78,193
Closed -$643K 740
2025
Q1
$643K Buy
+78,193
New +$656K ﹤0.01% 607
2024
Q3
Sell
-1,542,079
Closed -$15.8M 752
2024
Q2
$15.8M Sell
1,542,079
-373,145
-19% -$4.09M 0.02% 353
2024
Q1
$22.7M Buy
1,915,224
+148,521
+8% +$1.65M 0.03% 312
2023
Q4
$18.9M Sell
1,766,703
-51,776
-3% -$630K 0.03% 334
2023
Q3
$24.8M Buy
+1,818,479
New +$26.6M 0.03% 288

Other funds holding PTEN

Boston Partners's PTEN Position: Q2 2025 in Review

Boston Partners sold out of Patterson-UTI (PTEN) in Q2 2025, closing a stake of 78,193 shares — an estimated $643K sold.

Boston Partners first reported a position in PTEN in Q3 2023 and held it in 5 quarters. The position peaked at $24.8M in Q3 2023. 360 funds tracked by Wall St. Rank hold PTEN as of Q2 2025.

  • Boston Partners reported no remaining Patterson-UTI position as of Q2 2025 after selling out during the quarter.
  • Boston Partners sold 78,193 Patterson-UTI shares in Q2 2025, an estimated $643K.
  • Boston Partners first reported a position in Patterson-UTI in Q3 2023 and held it in 5 quarters.
  • Boston Partners's Patterson-UTI position peaked at $24.8M in Q3 2023.
  • 360 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2025.

Based on Boston Partners's 13F filing for Q2 2025, filed 7 Aug 2025.